Summary: Transcutaneous electric nerve stimulation, a treatment commonly administered for bladder dysfunction, appears to improve sexual response in women who suffer female sexual dysfunction.
Source: University of Michigan.
Electrodes aren’t the first thing most people think of when it comes to achieving sexual arousal. But if the results of a pilot study are any indication, that may soon change.
Female sexual dysfunction (FSD), a condition that ranges from a lack of libido to an inability to achieve orgasm, affects 40 to 45 percent of women, especially as they age.
FSD can be tough to diagnose and even more difficult to treat.
And while clinicians have attempted to help women by prescribing sildenafil (better known by its brand name, Viagra), hormones, and flibanserin these methods don’t always work and can have undesirable side effects.
That’s why two University of Michigan researchers were intrigued after learning that neuromodulation treatments for bladder dysfunction occasionally led to improvements in sexual function.
“In this particular treatment, a patient receives nerve stimulation therapy once a week to improve neural signaling and function in the muscles that control the bladder,” says Tim Bruns, Ph.D., an assistant professor of biomedical engineering at U-M. “The nerves controlling the pelvic organs start out in the same location in the spinal cord and branch out.”
Interestingly, Bruns notes, one form of stimulation is effective for bladder dysfunction despite an odd placement of the electrodes: near the tibial nerve in the ankle.
The current theory, Bruns explains, is that the nerves that travel down to the foot overlap near the spinal cord with some of the nerves to the pelvic organs, leading to a possible overlap in synaptic routes.
Sensing an opportunity, Bruns and his colleague, Nicholas Langhals, Ph.D., looked into whether the technique had been investigated in women without bladder problems.
Surprisingly, there was almost no research.
Testing a theory
Bruns decided to study the technique in rats and humans.
In the rat studies published last year and earlier this year, Bruns’ team stimulated nerves in the genital and ankle region. After 15 to 30 minutes, the rodents experienced a strong increase in vaginal blood flow.
Then, working with Michigan Medicine obstetrician-gynecologist Mitchell Berger, M.D., Ph.D., and urologic surgeon Priyanka Gupta, M.D., the researchers recruited nine women with FSD (and without bladder problems) for a pilot study.
Each woman received 12 half-hour sessions of transcutaneous electrical nerve stimulation in which participants had electrodes placed either in the genital region or on the ankle.
A 53-year-old woman who got involved with the study after reporting difficulty achieving orgasm to her gynecologist, described the experience as “a bizarre, pressure vibration sensation.”
Still, she managed. “After a few minutes, however, you get used to it,” the participant recalled. “Then, you sit there for 30 minutes. I brought a book to read during my session.”
Electrodes boost sexual function
Results of the sessions showed substantial promise: Eight of out the nine women reported some improvement in arousal, lubrication and orgasm.
“Across a variety of clinical studies, if you get a 50 percent improvement in symptoms, you can consider that a successful response,” Bruns says. “We had four participants meet or exceed that threshold.”
Overall improvement in score was comparable or greater than prior studies of different types of drugs or neuromodulation for FSD, he adds. However, future studies with blinding and a placebo control are needed to rule out any placebo effect.
This study, published in the journal Neuromodulation, was funded in part by a grant from the Michigan Institute for Clinical and Health Research, which is funded by the National Institutes of Health.
More research planned
Bolstered by these early findings, the Michigan team is currently seeking funding to carry out a larger study.
Says Gupta: “This study presents an alternative method for treating female sexual dysfunction that is non-pharmacologic and non-invasive. Through studies like this we can further understand female sexual arousal and offer treatments for a disorder that has very few options.”
The treatment definitely has at least one fan: the participant interviewed about her experience.
“It worked for me,” she says. “I’m not one-hundred percent back to the way I was, but I can have orgasms again and they are pretty good ones.”
Funding: This study was funded by NIH.
Source: Kelly Malcom – University of Michigan
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is in the public domain.
Original Research: Abstract for “Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study” by Lauren L. Zimmerman MS, Priyanka Gupta MD, Florence O’Gara BSN, MSW, Nicholas B. Langhals PhD, Mitchell B. Berger MD, PhD, and Tim M. Bruns PhD in Neuromodulation. Published September 3 2018.
[cbtabs][cbtab title=”MLA”]University of Michigan”Simple Nerve Stimulation May Improve Sexual Response in Women.” NeuroscienceNews. NeuroscienceNews, 5 September 2018.
<https://neurosciencenews.com/women-sexual-response-9799/>.[/cbtab][cbtab title=”APA”]University of Michigan(2018, September 5). Simple Nerve Stimulation May Improve Sexual Response in Women. NeuroscienceNews. Retrieved September 5 2018 from https://neurosciencenews.com/women-sexual-response-9799/[/cbtab][cbtab title=”Chicago”]University of Michigan”Simple Nerve Stimulation May Improve Sexual Response in Women.” https://neurosciencenews.com/women-sexual-response-9799/ (accessed September 5 2018).[/cbtab][/cbtabs]
Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study
To perform a pilot study using transcutaneous electrical nerve stimulation (TENS) on the dorsal genital nerve and the posterior tibial nerve for improving symptoms of female sexual dysfunction (FSD) in women without bladder problems. We hypothesize that this therapy will be effective at improving genital arousal deficits.
Materials and Methods
Nine women with general FSD completed the study. Subjects received 12 sessions of transcutaneous dorsal genital nerve stimulation (DGNS; n = 6) or posterior tibial nerve stimulation (PTNS; n = 3). Stimulation was delivered for 30 min at 20 Hz. Sexual functioning was evaluated with the female sexual functioning index (FSFI), and surveys were also given on general health, urological functioning, and the Patients’ Global Impression of Change (PGIC) after treatment. Surveys were given before treatment (baseline), after 6 and 12 weeks of treatment, and 6 weeks after the completion of stimulation sessions.
The average total FSFI score across all subjects significantly increased from 15.3 ± 4.8 at baseline to 20.3 ± 7.8 after six sessions, 21.7 ± 7.5 after 12 sessions, and 21.3 ± 7.1 at study completion (p < 0.05 for all time points). Increases were observed in both DGNS and PTNS subjects. Significant FSFI increases were seen in the subdomains of lubrication, arousal, and orgasm, each of which is related to genital arousal. Bladder and general health surveys did not change across the study. PGIC had a significant increase.
This study provides evidence that transcutaneous stimulation of peripheral nerves has the potential to be a valuable therapeutic tool for women with FSD.